Testing for SARS-CoV-2: Can We Stop at 2?

Tau Hong Lee; Ray Junhao Lin; Raymond T P Lin; Timothy Barkham; Pooja Rao; Yee-Sin Leo; David Chien Lye; Barnaby Young; National Centre for Infectious Diseases COVID-19 Outbreak Research Team

doi:10.1093/cid/ciaa459

Testing for SARS-CoV-2: Can We Stop at 2?

Clin Infect Dis. 2020 Nov 19;71(16):2246-2248. doi: 10.1093/cid/ciaa459.

Authors

Tau Hong Lee^{1

2

3

4}, Ray Junhao Lin^{1

2}, Raymond T P Lin¹, Timothy Barkham^{2

4}, Pooja Rao^{2

3}, Yee-Sin Leo^{1

2

3

4

5}, David Chien Lye^{1

2

3

4}, Barnaby Young^{1

2

3}; National Centre for Infectious Diseases COVID-19 Outbreak Research Team

Affiliations

¹ National Centre for Infectious Diseases, Singapore.
² Tan Tock Seng Hospital, Singapore.
³ Lee Kong Chian School of Medicine, Singapore.
⁴ Yong Loo Lin School of Medicine, Singapore.
⁵ Saw Swee Hock School of Public Health, Singapore.

Abstract

The COVID-19 epidemic requires accurate identification and isolation of confirmed cases for effective control. This report describes the effectiveness of our testing strategy and highlights the importance of repeat testing in suspected cases in our cohort.

Keywords: COVID-19; SARS-CoV-2; diagnosis; polymerase chain reaction; testing.

Publication types

Case Reports

MeSH terms

Adult
COVID-19 / diagnosis*
COVID-19 Nucleic Acid Testing / methods*
Female
Humans
Male
Nasopharynx / virology*
Radiography
SARS-CoV-2 / isolation & purification*
Sampling Studies
Thorax / diagnostic imaging
Time Factors